Recently Launched!
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Historical Deciles for [NVO] Novo Nordisk
Data updated 2023-Mar-24 (Friday)Compare current performance/technical metrics to history for Novo Nordisk. Range of values presented below in deciles puts current values into historical context (Up to 5-years)
Provided As-is for informational/educational purposes only and should not be construed as investment advice . Past performance may not be not indicative of future results. Always consult your Investment Adviser before any decision
Share
Use widget to view Historical Metric Deciles for other Stocks/ETFs/Indices
Summary 2023-Mar-24 Friday
| Day Change | +2.12% Top | Day Volatility | 3.00% Top |
| Streak | ↑ 2 days Top | % Streak | +4.13% Top |
| RSI | 70 Top | CCI | 226.0 Top |
| MACD | 0.9 Top | ATR | 3.05 Mid |
| ADX | 17.0 Low | SSO | 89.9 Top |
| Change | Volatility | % off SMA | |
|---|---|---|---|
| 5-day | +9.55% Top | 8.36% Top | +3.22% Top |
| 10-day | +8.11% Top | 13.54% Top | +5.88% Top |
| 20-day | +7.87% Mid | 13.54% Mid | +6.38% Top |
| 50-day | +15.21% Top | 18.09% Low | +8.23% Mid |
| 100-day | +40.19% Top | 45.03% Mid | +14.96% Mid |
| 200-day | -34.09% Low | 147.15% Mid | -3.70% Low |
Choose Metric type
Select Performance timeframe above to analyze
On 2023-Mar-24, Novo Nordisk had:daily change of +2.12% intraday volatility of 3.0% 2 ↑(up) day streak yielding +4.13% See how this compares to historical ranges below. Upto last 5 years are bucketed into deciles (click on chart line for details) with 2023-Mar-24 value annotated for comparison
Related to Novo Nordisk
Information for Novo Nordisk
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Dividend History : History of Dividend Yield
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets Currently Viewing
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Jun-06 on Google
SEC Reports : Quarterly reports around 2025-Jun-06 on SEC Edgar
Compare Novo Nordisk with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Novo Nordisk
Industry : Pharmaceuticals industry performance which includes Novo Nordisk